Logo image of GRND

GRINDR INC (GRND) Stock Fundamental Analysis

NYSE:GRND - New York Stock Exchange, Inc. - US39854F1012 - Common Stock - Currency: USD

18.24  +0.31 (+1.73%)

After market: 17.9011 -0.34 (-1.86%)

Fundamental Rating

5

Taking everything into account, GRND scores 5 out of 10 in our fundamental rating. GRND was compared to 71 industry peers in the Interactive Media & Services industry. Both the profitability and the financial health of GRND get a neutral evaluation. Nothing too spectacular is happening here. GRND is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

GRND had negative earnings in the past year.
In the past year GRND had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: GRND reported negative net income in multiple years.
Each year in the past 5 years GRND had a positive operating cash flow.
GRND Yearly Net Income VS EBIT VS OCF VS FCFGRND Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M

1.2 Ratios

The Return On Assets of GRND (-11.38%) is comparable to the rest of the industry.
GRND has a better Return On Invested Capital (18.06%) than 90.91% of its industry peers.
The Average Return On Invested Capital over the past 3 years for GRND is significantly below the industry average of 12.64%.
The 3 year average ROIC (6.98%) for GRND is below the current ROIC(18.06%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -11.38%
ROE N/A
ROIC 18.06%
ROA(3y)-3.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6.98%
ROIC(5y)N/A
GRND Yearly ROA, ROE, ROICGRND Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 100 200 300

1.3 Margins

Looking at the Operating Margin, with a value of 28.15%, GRND belongs to the top of the industry, outperforming 93.94% of the companies in the same industry.
Looking at the Gross Margin, with a value of 74.36%, GRND is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
In the last couple of years the Gross Margin of GRND has grown nicely.
Industry RankSector Rank
OM 28.15%
PM (TTM) N/A
GM 74.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.95%
GM growth 5YN/A
GRND Yearly Profit, Operating, Gross MarginsGRND Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so GRND is creating value.
GRND has more shares outstanding than it did 1 year ago.
The debt/assets ratio for GRND has been reduced compared to a year ago.
GRND Yearly Shares OutstandingGRND Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 50M 100M 150M
GRND Yearly Total Debt VS Total AssetsGRND Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 100M 200M 300M 400M 500M

2.2 Solvency

GRND has an Altman-Z score of 5.26. This indicates that GRND is financially healthy and has little risk of bankruptcy at the moment.
GRND has a better Altman-Z score (5.26) than 77.27% of its industry peers.
GRND has a debt to FCF ratio of 4.00. This is a good value and a sign of high solvency as GRND would need 4.00 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.00, GRND is doing good in the industry, outperforming 65.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4
Altman-Z 5.26
ROIC/WACC1.95
WACC9.25%
GRND Yearly LT Debt VS Equity VS FCFGRND Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M

2.3 Liquidity

GRND has a Current Ratio of 1.46. This is a normal value and indicates that GRND is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of GRND (1.46) is worse than 60.61% of its industry peers.
GRND has a Quick Ratio of 1.46. This is a normal value and indicates that GRND is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of GRND (1.46) is worse than 60.61% of its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.46
GRND Yearly Current Assets VS Current LiabilitesGRND Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M 80M

More info and screens

6

3. Growth

3.1 Past

GRND shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -899.23%.
Looking at the last year, GRND shows a very strong growth in Revenue. The Revenue has grown by 31.78%.
Measured over the past years, GRND shows a very strong growth in Revenue. The Revenue has been growing by 35.45% on average per year.
EPS 1Y (TTM)-899.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
Revenue 1Y (TTM)31.78%
Revenue growth 3Y35.45%
Revenue growth 5YN/A
Sales Q2Q%27.13%

3.2 Future

GRND is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.62% yearly.
The Revenue is expected to grow by 15.55% on average over the next years. This is quite good.
EPS Next Y114.34%
EPS Next 2Y83.57%
EPS Next 3Y57.77%
EPS Next 5Y34.62%
Revenue Next Year33.22%
Revenue Next 2Y28.44%
Revenue Next 3Y26.3%
Revenue Next 5Y15.55%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GRND Yearly Revenue VS EstimatesGRND Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
GRND Yearly EPS VS EstimatesGRND Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6 0.8

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

GRND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 41.59, GRND can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of GRND is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 22.65. GRND is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 41.59
GRND Price Earnings VS Forward Price EarningsGRND Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

GRND's Enterprise Value to EBITDA ratio is in line with the industry average.
GRND's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 43.75
EV/EBITDA 31.79
GRND Per share dataGRND EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GRND's earnings are expected to grow with 57.77% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y83.57%
EPS Next 3Y57.77%

More info and screens

0

5. Dividend

5.1 Amount

GRND does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GRINDR INC

NYSE:GRND (2/26/2025, 8:04:01 PM)

After market: 17.9011 -0.34 (-1.86%)

18.24

+0.31 (+1.73%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)03-05 2025-03-05/amc
Inst Owners16.66%
Inst Owner Change-93.41%
Ins Owners22.91%
Ins Owner Change-1.61%
Market Cap3.22B
Analysts82
Price Target20.4 (11.84%)
Short Float %29.67%
Short Ratio8.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-164.43%
Min EPS beat(2)-354.9%
Max EPS beat(2)26.05%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.5%
Min Revenue beat(2)1.5%
Max Revenue beat(2)3.5%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.56%
PT rev (3m)27.66%
EPS NQ rev (1m)15.56%
EPS NQ rev (3m)44.45%
EPS NY rev (1m)12.5%
EPS NY rev (3m)228.57%
Revenue NQ rev (1m)4.16%
Revenue NQ rev (3m)8.38%
Revenue NY rev (1m)0.58%
Revenue NY rev (3m)1.98%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 41.59
P/S 10.1
P/FCF 43.75
P/OCF 41.06
P/B N/A
P/tB N/A
EV/EBITDA 31.79
EPS(TTM)-0.3
EYN/A
EPS(NY)0.44
Fwd EY2.4%
FCF(TTM)0.42
FCFY2.29%
OCF(TTM)0.44
OCFY2.44%
SpS1.81
BVpS-0.08
TBVpS-2.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.38%
ROE N/A
ROCE 22.86%
ROIC 18.06%
ROICexc 20.05%
ROICexgc N/A
OM 28.15%
PM (TTM) N/A
GM 74.36%
FCFM 23.07%
ROA(3y)-3.73%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6.98%
ROIC(5y)N/A
ROICexc(3y)7.41%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.83%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.95%
GM growth 5YN/A
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4
Debt/EBITDA 2.59
Cap/Depr 27.14%
Cap/Sales 1.51%
Interest Coverage 2.71
Cash Conversion 72.9%
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.46
Altman-Z 5.26
F-Score6
WACC9.25%
ROIC/WACC1.95
Cap/Depr(3y)13.11%
Cap/Depr(5y)11.67%
Cap/Sales(3y)2.37%
Cap/Sales(5y)2.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-899.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50%
EPS Next Y114.34%
EPS Next 2Y83.57%
EPS Next 3Y57.77%
EPS Next 5Y34.62%
Revenue 1Y (TTM)31.78%
Revenue growth 3Y35.45%
Revenue growth 5YN/A
Sales Q2Q%27.13%
Revenue Next Year33.22%
Revenue Next 2Y28.44%
Revenue Next 3Y26.3%
Revenue Next 5Y15.55%
EBIT growth 1Y86.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year127.05%
EBIT Next 3Y50.03%
EBIT Next 5Y30.6%
FCF growth 1Y56.18%
FCF growth 3Y11.19%
FCF growth 5YN/A
OCF growth 1Y49.8%
OCF growth 3Y11.52%
OCF growth 5YN/A